Navigation Links
Prioritizing lab testing for patients on antiretroviral treatment in resource-constrained settings
Date:4/18/2012

In this week's PLoS Medicine, Luis Montaner from the Wistar Institute, Philadelphia, USA and colleagues retrospectively apply a potential capacity-saving CD4 count model to a cohort of HIV-infected patients on antiretroviral therapy. The study's findings suggest that the model could be used to optimize laboratory capacity in settings where resources are limited. The authors stress that the method is not intended to replace CD4 count testing or establish a second tier of healthcare, rather the model is intended as a triage tool to prioritize laboratory capacity for patients who are a high priority.

The authors state: "the implementation of our method could help focus laboratory-based CD4 count testing capacity on patients with higher likelihood of CD4 failure. This work provides the basis for future prospective testing of the model's overall safety, cost effectiveness and clinical outcomes in low-resource settings."


'/>"/>
Contact: Katie Hickling
press@plos.org
Public Library of Science
Source:Eurekalert

Page: 1

Related biology technology :

1. Arsenic Testing Proves Organic Baby Formula Safe
2. Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
3. HPV Testing for Cervical Cancer Risk Patients set to Increase
4. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. LABS, Inc. Earns AABB Accreditation for Donor Testing
7. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
8. VetNostic Laboratories® Announces New Testing for Dog Breeds
9. US Microbiology Testing Market
10. HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient
11. New White Paper Examines Clinical Trial Material Production & Testing: What Your Contract Manufacturing Organization is Not Telling You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 22, 2017 , ... NetDimensions has ... the Aragon Research Globe™ for Corporate Learning, 2017. , Aragon Research defines Leaders ... demand, and effectively perform against those strategies. NetDimensions’ ranking as a Leader due ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... ... sources for advanced technology applications, has announced a facility expansion to accommodate its ... 3,000 square feet of new workspace and renovation of the existing areas. The ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Cambridge Semantics ... splash at this year’s Bio-IT World Conference and Expo in Boston May ... Lake® 4.0 solution. The Anzo Smart Data Lake is also a finalist for ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... other leaders of the Maryland Biohealth community in developing and issuing recommendations to ... 3 U.S. BioHealth Innovation Hub by 2023. , The recommendations ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):